Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.78 |
| ▸ | EBP | Q15125 | 2/20 | 0.78 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.78 |
| ▸ | EBPL | Q9BY08 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| [11C]Sa4503 SCHEMBL968642 | 0.88 | SIGMAR1 (1.00) | SIGMAR1EBPTMEM97EBPL | |
| [11C]Sa4503 SCHEMBL29358558 | 0.88 | SIGMAR1 (1.00) | SIGMAR1EBPTMEM97EBPL | |
| SCHEMBL1298738 | 0.87 | SIGMAR1 (0.84) | SIGMAR1EBPTMEM97EBPL | |
| [11C]Sa4503 SCHEMBL1299046 | 0.87 | SIGMAR1 (0.97) | SIGMAR1EBPTMEM97EBPL | |
| Hydrochloric Acid SCHEMBL8088187 | 0.87 | SIGMAR1 (0.97) | SIGMAR1EBPTMEM97EBPL | |
| [11C]Sa4503 SCHEMBL29358694 | 0.87 | SIGMAR1 (0.97) | SIGMAR1EBPTMEM97EBPL | |
| SCHEMBL8083210 | 0.86 | SIGMAR1 (0.95) | SIGMAR1EBPTMEM97EBPL | |
| SCHEMBL8086559 | 0.85 | SIGMAR1 (0.92) | SIGMAR1EBPTMEM97EBPL | |
| Hydrochloric Acid SCHEMBL8075024 | 0.84 | SIGMAR1 (0.92) | SIGMAR1EBPTMEM97EBPL | |
| Hydrochloric Acid SCHEMBL8086545 | 0.83 | SIGMAR1 (0.90) | SIGMAR1EBPTMEM97EBPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11242314-B2 | Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride | WASHINGTON UNIVERSITY (US) | 2022-02-08 | — | — | US | disclosed |
| US-20130005956-A1 | Synthesis of 18F-labeled Tracers in Hydrous Organic Solvents | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2013-01-03 | — | — | US | disclosed |
| US-20120189546-A1 | Radiolabelling Method Using Cycloalkyl Groups | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11242314-B2 | Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride | STX18, GPR119, SLC5A1 | SIGMAR1 855/4885EBP 2361/4885TMEM97 237/4885 |
| US-20130005956-A1 | Synthesis of 18F-labeled Tracers in Hydrous Organic Solvents | SLCO1B1, SLCO4C1, SLCO2B1 | SIGMAR1 729/4885EBP 547/4885TMEM97 791/4885 |
| US-20120189546-A1 | Radiolabelling Method Using Cycloalkyl Groups | TMEM14C, PAICS, QPCT | SIGMAR1 2185/4885EBP 1415/4885TMEM97 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.